A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S.
20240326113011.png&width=300&height=300){kind=logo}
It’s peak cold and flu season in the northern hemisphere. Four papers published in ACS journals provide insights into novel antiviral compounds and methods to inactivate infectious viral particles and bacteria.
Using an AI-driven decision support system to predict the severity of COVID-19 and identify best interventions, researchers analyzed electronic health record data from 5,371 patients admitted to a South Florida hospital. The study specifically aimed to forecast the likelihood of patients requiring admission to an ICU, with or without mechanical ventilation, or an intermediate care unit (IMCU). The goal was to leverage these features to enable faster and more accurate forecasting of treatment plans, potentially preventing critical conditions from worsening.
A study by the Università Cattolica, Rome campus - Fondazione Policlinico Universitario A. Gemelli IRCCS and the Ospedale Pediatrico Bambino Gesù IRCCS, published in the Nature Group journal ‘Pediatric Research’, identifies the ‘protein signature’ of the condition in plasma, a group of pro-inflammatory molecules present at high concentrations in young patients with the condition.
Mount Sinai cardiologists warn about the risk of heart problems during surge of winter viruses for American Heart Month in February
It’s time to get a better read on how infectious diseases are tied to the loss of biodiversity worldwide, an international team of scientists argue in a new paper.
The weather’s frosty, pine mist floats on the wind, and the distinctive aromas of cozy fireplaces, seasonal baking and hot cider fill the air. But winter’s scents aren’t the only things being spread.
A new study that identified 475 patients with post-acute sequelae of Covid-19 (PASC), or Long Covid, revealed that nearly 85 percent (403) of these patients had multiple Covid-19 infections over the course of a four-year period.
A new study published in the Journal of General Internal Medicine reveals that infection with SARS-CoV-2, the virus that causes COVID-19, significantly increases the rate of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) among COVID-19 survivors.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 海角社区 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
